150 related articles for article (PubMed ID: 6186451)
1. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
Kirby ML; Mattio TG
Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
[TBL] [Abstract][Full Text] [Related]
2. Effects of neonatal 5,7-dihydroxytryptamine treatment on the development of serotonin neurons and their transmitter metabolism.
Ponzio F; Jonsson G
Dev Neurosci; 1978; 1(2):80-9. PubMed ID: 755684
[No Abstract] [Full Text] [Related]
3. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
Mueller RA; Towle A; Breese GR
Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
[TBL] [Abstract][Full Text] [Related]
4. Increased tryptophan hydroxylase activity in serotonergic nerve terminals spared by 5,7-dihydroxytryptamine.
Stachowiak MK; Stricker EM; Jacoby JH; Zigmond MJ
Biochem Pharmacol; 1986 Apr; 35(8):1241-8. PubMed ID: 2421731
[TBL] [Abstract][Full Text] [Related]
5. Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord.
Brown LM; Smith DL; Williams GM; Smith DJ
Neurosci Lett; 1989 Jul; 102(1):103-7. PubMed ID: 2779841
[TBL] [Abstract][Full Text] [Related]
6. GM1 ganglioside counteracts selective neurotoxin-induced lesion of developing serotonin neurons in rat spinal cord.
Fusco M; Donà M; Tessari F; Hallman H; Jonsson G; Gorio A
J Neurosci Res; 1986; 15(4):467-79. PubMed ID: 3522923
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
Fischette CT; Nock B; Renner K
Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
[TBL] [Abstract][Full Text] [Related]
8. Influences of both thyroid and bovine growth hormones on substance P, thyrotropin-releasing hormone, serotonin and 5-hydroxyindoleacetic acid contents in the lumbar spinal cord of developing rats.
Savard P; Blanchard LM; Mérand Y; Bédard P; Dussault JH; Dupont A
Brain Res; 1984 Mar; 315(1):105-10. PubMed ID: 6202374
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
Warbritton JD; Stewart RM; Baldessarini RJ
Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting depletion of spinal cord 5-hydroxytryptamine or catecholamines after intraspinal injection of 5,7-dihydroxytryptamine or 6-hydroxydopamine to newborn rats.
Carruba MO; Keller HH; Da Prada M
Neurosci Lett; 1983 Feb; 35(2):173-8. PubMed ID: 6190112
[No Abstract] [Full Text] [Related]
11. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord.
Sharif NA; Towle AC; Burt DR; Mueller RA; Breese GR
Brain Res; 1989 Feb; 480(1-2):365-71. PubMed ID: 2540880
[TBL] [Abstract][Full Text] [Related]
12. Early postnatal administration of 5,7-dihydroxytryptamine: effects on substance P and thyrotropin-releasing hormone neurons and terminals in rat brain.
Towle AC; Breese GR; Mueller RA; Hunt R; Lauder JM
Brain Res; 1986 Jan; 363(1):38-46. PubMed ID: 2418913
[TBL] [Abstract][Full Text] [Related]
13. Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5.7-dihydroxytryptamine injection.
Barbeau H; Bédard P
Neuropharmacology; 1981 May; 20(5):477-81. PubMed ID: 6165921
[No Abstract] [Full Text] [Related]
14. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
Hutson PH; Tricklebank MD; Curzon G
Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
[TBL] [Abstract][Full Text] [Related]
15. Endogenous levels of serotonin and 5-hydroxyindoleacetic acid in specific areas of the pigeon CNS: effects of serotonin neurotoxins.
Alesci R; Bagnoli P
Brain Res; 1988 May; 450(1-2):259-71. PubMed ID: 2456822
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin releasing hormone but not histidyl-proline diketopiperazine is depleted from rat spinal cord following 5,7-dihydroxytryptamine treatment.
Lechan RM; Jackson IM
Brain Res; 1985 Feb; 326(1):152-5. PubMed ID: 3918765
[TBL] [Abstract][Full Text] [Related]
17. Developmental alterations in 5-hydroxytryptamine concentration and turnover after treatment of neonatal rats with 5,7-dihydroxytryptamine.
Mercugliano M; Nguyen H; Djali S; Lucki I
Neurobiol Learn Mem; 1996 Mar; 65(2):163-76. PubMed ID: 8833105
[TBL] [Abstract][Full Text] [Related]
18. Reduction of substance P levels in the ventral cervical spinal cord of the rat after intracisternal 5,7-dihydroxytryptamine injection.
Singer E; Sperk G; Placheta P; Leeman SE
Brain Res; 1979 Oct; 174(2):362-5. PubMed ID: 487135
[No Abstract] [Full Text] [Related]
19. Temporal effects of intrahypothalamic 5,7-dihydroxytryptamine: relationship between serotonin levels and [3H]serotonin binding.
Frankfurt M; Allen DL; Luine VN; Beaudet A
Brain Res; 1987 Sep; 419(1-2):216-22. PubMed ID: 2445421
[TBL] [Abstract][Full Text] [Related]
20. Effects of neonatal spinal cord serotonin depletion on opiate-induced analgesia in tests of thermal and mechanical pain.
Giordano J; Barr GA
Brain Res; 1988 Jun; 469(1-2):121-7. PubMed ID: 3401795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
